Ibogaine, a Psychedelic, and 1cP-MiPLA, a Psychedelic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Psychedelics, meaning they share a common pharmacological foundation. They share 41 documented effects in common, with 30 effects unique to Ibogaine and 29 unique to 1cP-MiPLA. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Interaction |
| Low Risk & Synergy |
| Level | Ibogaine | 1cP-MiPLA |
|---|---|---|
| Threshold | — mg/kg of body weight | 50 µg |
| Light | — mg/kg of body weight | 100–150 µg |
| Common | 15–22 mg/kg of body weight | 150–200 µg |
| Strong | — mg/kg of body weight | 200–250 µg |
| Heavy | — mg/kg of body weight | 300 µg |
Ibogaine
1cP-MiPLA
Cross-tolerance exists; effects compound
No dangerous interactions recorded.
No dangerous interactions recorded.